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Abstract
Background
There are racial, ethnic and geographical differences in complete blood count (CBC) refer-
ence intervals (RIs) and therefore it is necessary to establish RIs that are population spe-
cific. Several studies have been carried out in Africa to derive CBC RIs but many were not
conducted with the rigor recommended for RI studies hence limiting the adoption and gener-
alizability of the results.
Method
By use of a Beckman Coulter ACT 5 DIFF CP analyser, we measured CBC parameters in
samples collected from 528 healthy black African volunteers in a largely urban population.
The latent abnormal values exclusion (LAVE) method was used for secondary exclusion of
individuals who may have had sub-clinical diseases. The RIs were derived by both paramet-
ric and non-parametric methods with and without LAVE for comparative purposes.
Results
Haemoglobin (Hb) levels were lower while platelet counts were higher in females across
the 4 age stratifications. The lower limits for Hb and red blood cell parameters significantly
increased after applying the LAVE method which eliminated individuals with latent anemia
and inflammation. We adopted RIs by parametric method because 90% confidence inter-
vals of the RI limits were invariably narrower than those by the non-parametric method. The
male and female RIs for Hb after applying the LAVE method were 14.5–18.7 g/dL and 12.0–
16.5 g/dL respectively while the platelet count RIs were 133–356 and 152–443 x103 per μL
respectively.
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Conclusion
Consistent with other studies from Sub-Saharan Africa, Hb and neutrophil counts were
lower than Caucasian values. Our finding of higher Hb and lower eosinophil counts com-
pared to other studies conducted in rural Kenya most likely reflects the strict recruitment
criteria and healthier reference population after secondary exclusion of individuals with pos-
sible sub-clinical diseases.
Introduction
Reference intervals (RIs) play an important role in guiding the interpretation of laboratory
results. However, several factors influence RIs with the notable sources of variation being age,
sex, race, body mass index (BMI) and ethnicity [1,2]. Use of inappropriate RIs can result in
misclassification of patients and subsequent mismanagement [3]. For this reason, it is recom-
mended that laboratories determine RIs that are appropriate for the population they serve or
at the very least verify any proposed RIs [4].
Few studies have been carried out in Africa to derive RIs and these have been done mainly
while conducting HIV related clinical trials since adopting inappropriate RIs may result in
unnecessary exclusion of potential trial volunteers and makes assessment of laboratory adverse
events difficult. It is known that there are racial differences in complete blood count (CBC)
parameters. Beutler et al. clearly demonstrated that African-Americans had lower haemoglo-
bin (Hb), haematocrit (Hct), white blood cell count (WBC) and absolute granulocyte count
compared to European-Americans but higher lymphocyte counts [5]. Karita et al. carried out
a study to determine RIs for common haematology and chemistry tests in Kenya, Uganda,
Zambia and Rwanda. The study found lower Hct, Hb, WBC and neutrophil counts compared
to RIs from the United States (US) while eosinophil counts were found to be higher [6]. A sim-
ilar study was carried out in Kericho, a rural area situated in the highlands of the Great Rift
Valley in Kenya. The derived RIs for males and females were 8.3–11.3g/dL and 5.9–10.0 g/dL
respectively. A number of participants were found to have relatively low mean corpuscular vol-
ume (MCV) and haemoglobin (MCH), values consistent with iron deficiency especially in
women of child bearing age. Lower neutrophil and higher eosinophil counts compared to Cau-
casians were also found [7]. A genetic deletion of the Duffy antigen receptor for chemokines
(DARC-null genotype), a receptor for Plasmodium vivax, is thought to contribute to the
benign neutropenia seen in Africans and African-Americans [8]. The eosinophilia is thought
to be related to increased exposure to environmental allergens and possibly parasite infections
but there isn’t strong evidence to support this hypothesis.
These studies demonstrate the need to establish population specific RIs. However, establish-
ment of RIs should follow a rigorous process of identifying reference individuals, standardiza-
tion of sample handling and analysis as well as the use of appropriate statistical methods [9].
Despite all attempts to ensure that only healthy individuals are included in a RI study, this can
never be achieved due to the presence of subclinical disease in subjectively healthy individuals.
Reference individuals are also quite heterogeneous in their state of health and there isn’t a per-
fect standard to define health or normality [10]. Statistical methods such as latent abnormal
values exclusion (LAVE) have been devised in order to secondarily exclude healthy individuals
participating in an RI study but who have multiple related laboratory test values outside their
RIs suggesting the possibility of sub-clinical diseases [11].
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A criticism of RI studies especially those done in economically disadvantaged areas is that
the recruited population may not necessarily be representative of an ideal reference popula-
tion. There are different motivators to volunteer in a study and these can result in a selection
bias hence compromising the external validity of the study results [12,13]. We set out to
determine RIs for complete blood counts (CBCs) in Kenya using data from carefully selected
healthy individuals recruited as part of a multicenter, multi-country, global RI study con-
ducted by the Committee of Reference Intervals and Decision Limits (C-RIDL) under the aus-
pices of the International Federation of Clinical Chemistry (IFCC). Further, we compared our
RIs with those derived from similar studies in sub-Saharan Africa (SSA).
Methods
Setting
The study was carried out in Kenyan urban towns located in the counties of Nairobi, Thika,
Kiambu, Nakuru and Kisii. Recruitment was largely done from colleges, universities, churches,
hospitals, corporations and shopping malls. Awareness of the study was created through use
of posters, flyers, emails, church announcements and engaging administrators in the various
organizations.
Recruitment
A strict recruitment criteria was used when enrolling individuals for the study as stipulated
in the published study protocol and standard operating procedures [9]. Briefly, subjectively
healthy black African adults aged 18–65 years who had undergone an overnight fast were
recruited between January and October 2015. No financial inducements were given, however,
snacks were provided to those who participated. Recruitment was stratified into 4 age groups:
20–29, 30–39, 40–49 and 50–65 years with a similar distribution of males and females in each
age strata. Exclusion criteria included individuals with a body mass index (BMI) greater than
35 kg/m2, consumption of ethanol greater than or equal to 70 g per day [equivalent to 5 alco-
holic drinks], smoking more than 20 tobacco cigarettes per day, taking regular medication for
a chronic disease (diabetes mellitus, hypertension, hyperlipidemia, allergic disorders, depres-
sion), recent (less than 15 days) recovery from acute illness, injury or surgery requiring hospi-
talization, known carrier state of Hepatitis B, Hepatitis C or HIV, pregnant or within 1 year
after childbirth. Written informed consent was sought from each participant after giving a
written and verbal explanation of the study. Individuals with any chronic disease were
excluded except for the age group 50–65 years where individuals with well controlled hyper-
tension taking no more than 2 drugs were recruited. All participants had measurements of
blood pressure (BP), abdominal circumference and BMI done.
Pre-analytical sample handling
CBC samples were collected by a trained phlebotomist using an evacuated tube system com-
prising a sterile multi-sample needle, needle holder and plastic evacuated tubes containing eth-
ylene diamine tetra-acetic acid (EDTA) (BD Vacutainer1 Blood Collection Tube, US). The
samples were transported at refrigerated temperature and analyzed within 12 hours after col-
lection. Serum and plasma samples requiring centrifugation were spun within 4 hours after
collection and stored at -80˚C until shipment on dry ice to the reference laboratory in South
Africa for analysis of tests that were part of the global RI study. All samples arrived in the refer-
ence laboratory frozen and were only thawed once prior to sample analysis.
Complete blood count reference intervals from Kenya
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Sample analysis
All the sample analysis for the biochemistries and immunoassays were performed in the Path-
Care reference laboratory in Cape Town, South Africa, which is an International Organization
for Standardization (ISO) 15189 accredited laboratory. All participating countries in Africa
had their general biochemistry and immunoassays done in this laboratory so as to standardize
analysis, ensure alignment and comparison of results by using a common panel of sera across
all participating laboratories globally. The CBC parameters included red blood cell count
(RBC), Hb, Hct, MCV, MCH, mean corpuscular hemoglobin concentration (MCHC), red cell
distribution width (RDW), WBC, platelet (PLT), leukocyte differential counts of neutrophil
(Neu), lymphocyte (Lym), monocyte (Mon), eosinophil (Eos), basophil (Bas). The differential
counts were recorded as both % of WBC and absolute count (abs). The CBC was analysed
using a Beckman Coulter ACT 5 DIFF CP analyser (Brea, California, US) in the PathCare
Kenya laboratory based in Nairobi which is also ISO 15189 accredited by the South African
National Accreditation Service (SANAS).
Iron (Fe), transferrin (Tf), albumin (Alb), and ultrasensitive c-reactive protein (hsCRP)
were analysed using a Beckman Coulter AU5800 analyser while ferritin levels were determined
using a Beckman Coulter DXI analyser. The globulin fraction (Glb) was calculated by subtract-
ing Alb from total protein (TP). These non-CBC parameters were used as part of reference
tests in the LAVE procedure for secondary exclusion of individuals with latent anemia or
inflammation.
Ethics approval
The study was approved by the Aga Khan University Hospital Nairobi, Health research ethics
committee (2014/REC-46) and was carried out in accordance with the Declaration of Helsinki.
Statistical analysis
The sample size from each country participating in the global RI study was set at a minimum
of 500 (male and female: 250 × 2), so that country-specific RIs would be obtained in a more
reproducible manner. This number was deemed adequate to make between-country compari-
sons of test results with a power of detecting a difference of two means equivalent to 0.25 times
the standard deviation comprising the RI (SD RI), which corresponds to a bias of 0.25 times
between-individual variation, allowing errors of α less than 0.05 and β less than 0.2 in the sta-
tistical hypothesis testing done separately for each sex. According to the CLSI guideline [4], at
least 120 individuals are required to determine RIs using non-parametric methods for each
defined population group and for parameters not influenced by sex (60 females and 60 males).
For parameters that are influenced by sex, the minimum recommended number is 240 refer-
ence individuals (120 females and 120 males). Therefore, the sample size of 500 well exceeds
what is recommended by the CLSI and allows derivation of RIs with higher precision (nar-
rower 90% confidence intervals of the RI limits, or LL and UL). For comparative purposes, RIs
were determined using both parametric and non-parametric methods before and after apply-
ing the LAVE method as described by Ichihara et al. [14,15]. Briefly, for the non-parametric
method, the reference values coinciding with the 2.5th and 97.5th percentiles after arranging
the data in ascending order were used to identify the RI lower and upper limits (LL and UL).
For the parametric method, the data was transformed into a Gaussian form by using a modifi-
cation of the original Box-Cox power transformation formula as described by Ichihara [16],
ascertaining the mean and SD, and finally determining the RI as the mean ± 1.96SD, which
corresponds to the central 95% limits or LL and UL under transformed scale. Then, the limits
are reverse transformed to get the LL and UL in the original scale.
Complete blood count reference intervals from Kenya
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The LAVE method is an iterative optimization procedure which is applied in a situation
where mutually related analytes were tested simultaneously. Initially, RIs are determined for
each analyte independently using either a parametric (mean ± 1.96 SD after Gaussian transfor-
mation) or non-parametric (mid 95% range) method. From the second computation, any
individual who has two or more results outside the RIs derived in the previous computation
among the reference tests (see below) is excluded. This process was repeated six times at which
point the RIs were nearly stable. Of note is that need for exclusion of a reference value is deter-
mined using a set of pre-defined reference tests but not the test whose RI is being determined
[11]. In this study we chose the following 11 analytes as the reference tests: Alb, Glb, hsCRP,
Fe, Tf, ferritin, Hb, Hct, MCV, WBC, and PLT which can help identify individuals with latent
anemia and/or inflammation.
For judging the need to partition reference values by sex and age, we computed the stan-
dard deviation ratio (SDR) which represents a ratio of between-subgroup SD (variation of the
subgroup means from grand mean) to between-individual SD (approximately 1/4 the width
of RI). We performed 2-level nested ANOVA to compute between-sex SD and between-age
group SD after partitioning age as 18–29 years, 30–39 years, 40–49 years and 50–65 years. The
SDR for between-sex SD (SDRsex) and for between-age SD (SDRage) were computed as a
ratio to residual SD (or between-individual SD). Since between-age variation changes by sex,
we also computed SDRage for each sex by one way ANOVA. We considered SDR 0.40 as a
guide for judging the need for partitioning reference values by sex or age [11]. For analysing
the relationship between Hb and PLT, we performed least-square linear regression analysis
and the degree of the association was expressed by Pearson’s correlation coefficient. We quan-
tified the magnitude of change in RI lower limit (LL) and upper limit (UL) before and after
applying the LAVE procedure using the formulas SDR-LL = |LL+ − LL-|/ {(UL+ − LL+)/3.92}
and SDR-UL = |UL+ − UL-|/ {(UL+ − LL+)/3.92} where LL+, UL+ are the RI limits with appli-
cation of LAVE, while LL-, UL- are RI limits without application of LAVE [17]. We set 0.3 as a
critical value to define a significant change in LL or UL after application of LAVE. Analysis
was carried out using a general purpose statistical software, StatFlex version 6.0 (Artech Inc.,
Osaka, Japan).
Results
1. Volunteers recruited
A total of 596 individuals volunteered to participate in the study out of which 63 were excluded
for various reasons as shown in Fig 1. Out of 533 eligible participants, only 528 had CBC
results available with 254 (48.1%) being males. Five individuals were excluded because CBCs
were performed at a different laboratory using different equipment.
The median age for the included participants was 39 years with the youngest and oldest
being 18 and 65 years respectively as shown in Table 1. The number of participants in the
four age groups were 134 (18–29 years), 136 (30–39 years), 131 (40–49 years) and 127 (50–65
years). The number of smokers was low with only 2 (0.7%) and 13 (5.1%) women and men
respectively.
2. Sex and age related changes in reference values
Using a cut-off of 0.4, SDRs revealed that sex was a significant source of variation for RBC
count, Hb, Hct, PLT count, absolute monocyte count and percentage while age was a signifi-
cant source of variation only for absolute monocyte count and percentage in females as shown
in Table 2. For all other CBC parameters, age and sex did not appear to be major sources of
variation hence we chose not to partition their RIs.
Complete blood count reference intervals from Kenya
PLOS ONE | https://doi.org/10.1371/journal.pone.0198444 June 7, 2018 5 / 19
Reference values (RVs) of Hb, Hct and RBC were considerably lower in female participants
compared to males while PLT counts were higher in female participants. For the non CBC
parameters, RVs of serum iron and ferritin were lower in female participants but those of
transferrin were higher as shown in Fig 2.
There was a negative correlation between Hb level and platelet count with the magnitude
of the correlation coefficient being greater in females (r = −0.336) than compared to males
(r = −0.226) as shown in Fig 3.
3. Derivation of reference intervals
Without application of the LAVE method, RIs derived using the non-parametric method gener-
ally showed wider ranges and 90% CIs of the RI limits compared to the parametric method. This
tendency was more prominently seen in female participants especially for RBC, Hb, Hct, MCV,
MCH, RDW and PLT as shown in the graphical representation of RIs in Fig 4 and S1 Fig.
The LAVE procedure had a greater effect in females where it significantly raised the LLs
and narrowed the RIs for Hb, Hct, MCV, MCH and MCHC compared to males where the
Fig 1. Flow diagram for recruitment. BMI: body mass index, CBC: complete blood count, DM: diabetes mellitus,
HIV: Human Immunodeficiency Virus, HTN: hypertension On antibiotics, blood donation in past 3 months, on
treatment for hypothyroidism,> 65 years,> 65 years and hypertensive, rheumatic heart disease, prostate cancer.
https://doi.org/10.1371/journal.pone.0198444.g001
Table 1. Descriptive characteristics of participants (Median, 2.5~97.5 percentile).
Parameter Male (n = 255) Female (n = 273) Total (n = 528)
Age (years) 38.0 (21.0~64.0) 39.0 (20.0~61.7) 39.0 (20.0~63.0)
BMI (kg/m2) 24.9 (18.3~33.6) 26.1 (18.5~34.9) 25.5 (18.3~34.2)
SBP (mmHg) 81.0 (61.0~99.0) 79.0 (61.0~98.7) 80.0 (61.0~99.0)
DBP (mmHg) 127.0 (103.9~151.3) 118.0 (96.3~156.0) 123.5 (98.7~155.0)
BMI: body mass index, DBP: diastolic blood pressure, SBP: systolic blood pressure
https://doi.org/10.1371/journal.pone.0198444.t001
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LAVE resulted in a minor change in the LLs of RBC parameters. S1 Table shows the SDRs for
the change in LLs and ULs after application of the LAVE method. An SDR greater than 0.3
was considered a significant change in LL or UL by use of the LAVE method. On the other
hand, the LAVE method didn’t significantly alter LLs for WBC parameters but reduced ULs
for absolute basophil and neutrophil counts.
The parametrically derived female RI for Hb before applying the LAVE method was 10.6–
16.5 g/dL but changed to 12–16.5 g/dL after applying the method. In males, the LAVE method
changed the parametrically derived Hb RI from 14.2–18.7 g/dL to 14.5–18.7 g/dL. RIs for RBC
related parameters were consistently lower in females as shown in Table 3. RIs for PLT were
consistently higher in females with or without the LAVE method as shown in Table 3, S2 Fig
and S2 Table. The RIs that we chose to adopt based on whether sex was a major source of vari-
ation are highlighted in bold in Table 3.
A graphical representation of CBC RIs for selected studies carried out in SSA is given in
Figs 5 and 6 to enable comparison with our derived RIs. A summary of the same is provided as
S3 and S4 Tables.
Discussion
Several studies carried out in Africa have reported marked differences in some CBC parame-
ters when compared to Caucasian populations and even between different populations across
Africa as shown in S3 and S4 Tables. A fairly consistent finding has been the lower RIs for
absolute neutrophil counts in black African populations which is thought to be associated with
Table 2. Complete blood count standard deviation ratios for age and sex.
Item SDR-sex SDR-age SDR-age M SDR-age F
RBC 1.02 0.05 0.08 0.00
Hb 1.28 0.10 0.15 0.00
Hct 1.28 0.14 0.22 0.00
MCV 0.00 0.00 0.00 0.17
MCH 0.04 0.00 0.00 0.10
MCHC 0.19 0.00 0.00 0.15
RDW 0.13 0.00 0.00 0.00
WBC 0.00 0.13 0.12 0.14
Neu % 0.34 0.16 0.18 0.14
Lym % 0.16 0.08 0.19 0.00
Mon % 0.46 0.39 0.33 0.53
Eos % 0.13 0.14 0.14 0.13
Bas % 0.27 0.00 0.00 0.05
Neu Abs 0.22 0.00 0.00 0.04
Lym Abs 0.00 0.19 0.21 0.17
Mon Abs 0.33 0.42 0.34 0.53
Eos Abs 0.12 0.17 0.22 0.07
Bas Abs 0.20 0.08 0.00 0.20
PLT 0.41 0.00 0.00 0.00
%: Percentage, RBC: red blood cell count, Hb: haemoglobin, MCV: mean corpuscular volume, MCH: mean
corpuscular haemoglobin, MCHC: mean corpuscular haemoglobin concentration, RDW: red cell distribution width,
WBC: white blood cell count, Neu: neutrophil, Lym: lymphocyte, Mon: monocyte, Eos: eosinophil, Bas: basophil,
Abs: absolute count, Plt: platelet count, SDR: standard deviation ratio, M: male, F: female. SDRs > 0.4 are in bold
https://doi.org/10.1371/journal.pone.0198444.t002
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the DARC-null genotype, an evolutionary adaptation thought to make Africans less susceptible
to Plasmodium vivax infections [8]. In contrast to RIs from the US where the absolute neutro-
phil count RI is 1800–7700 cells/μL [26], the parametrically derived neutrophil count RI for
males and females in our study was significantly lower at 1050–4080 cells/μL, which is in keep-
ing with what has been found in other African studies [6,7,21]. Neutrophil count RIs with LLs
as low as 500 and 840 cells/uL have been reported in Togo and Uganda respectively as shown
in S4 Table.
Studies carried out in largely rural populations in SSA have revealed low Hb levels especially
in women. A study done in Kericho which is a rural town in Kenya located in The Great Rift
Valley at an altitude of over 2000 metres above sea level derived a Hb lower RI limit in women
of 5.9 g/dL [7] while a study by Karita et al. that involved 4 countries in SSA found a LL of 9.1
g/dL [27]. It is inconceivable that a Hb of 5.9 g/dL would be accepted as a LL even if clinically
one is not presenting with symptoms of anaemia. In the study by Karita et al., the Hb values
from one of the research sites situated in a university teaching hospital in Nairobi, Kenya were
excluded as they were significantly higher than the other study sites. Other than the compara-
tively higher altitude of Nairobi, the authors hypothesized that the Hbs of participants from
Nairobi were higher as they comprised mainly medical doctors and students considered to
be healthier due to better nutrition and access to healthcare. For this reason, the RVs from
Nairobi were subsequently excluded in the derivation of the consensus RI. This secondary
Fig 2. Sex and age-related changes for representative parameters. F: female, Ferr: ferritin, Hb: haemoglobin, M: male, MCV: mean corpuscular
volume, Plt: platelet count, RBC: red blood cell count, SDR: standard deviation ratio, Tf: transferrin.
https://doi.org/10.1371/journal.pone.0198444.g002
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exclusion of ‘healthier’ individuals may partly explain the low RI for Hb they derived [6].
According to the World Health Organization (WHO), a woman above 15 years of age with
a Hb that is less than 12 g/dl is considered anaemic [28]. Therefore, a large proportion of
women recruited in a number of studies summarized in Fig 5 were anaemic and given the low
RIs for MCV and MCH, the anaemia is in keeping with a microcytic hypochromic picture
commonly seen in iron deficiency. In SSA iron deficiency in women is likely due to poor
nutrition or blood loss as a result of menses or repeated childbirth.
We carefully recruited an urban population for our study using strict recruitment criteria,
and derived a RI for Hb in women of 12.0–16.5 g/dL after application of the LAVE method.
This RI for women is higher than that reported in most SSA studies but similar to published
RIs from the US of 12.0–16.0 g/dL [26]. The UL for the parametrically derived RI for male Hb
after LAVE was 18.7 g/dL which is significantly higher than what has been reported from most
studies in SSA but similar to the ULs of 18.3 and 18.4 g/dL reported from Ethiopia and Togo
respectively [20,24]. This most likely reflects our careful attempt to recruit well-defined healthy
individuals and secondarily exclude individuals with possible sub-clinical diseases by use of
the LAVE method. This resulted in an increase in the LLs of RBC parameters and narrowing
of RIs especially for female participants. This may explain the higher LLs for these parameters
in our study compared to other SSA studies that didn’t employ strict recruitment criteria or
secondary exclusion. The systematic removal of individuals with possible sub-clinical disease
makes our results more generalizable to an urban healthy black African population in Kenya.
The high UL for Hb seen especially in males in this study could be attributed to Nairobi’s rela-
tively high altitude of 1700 metres above sea level.
For the comparison of parametric and nonparametric methods, as shown in S2 Table, the
nonparametric method generally resulted in a wider RI, and wider 90% CIs of the RI limits. It
is attributable to the fact that parametric method has a step of exclusion of values outside mean
Fig 3. Relationship between platelet count and haemoglobin level. Hb: haemoglobin, Plt: platelet.
https://doi.org/10.1371/journal.pone.0198444.g003
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±3.5SD (probability: 0.00043 or 0.043%) after Gaussian transformation, as shown by a small
reduction in data size for the parametric method in most of the CBC parameters. This clearly
indicates the presence of extreme values not explained by chance, at the periphery of the distri-
bution. The recommendation by CLSI [4] that the nonparametric method be used in deter-
mining RIs was due to the difficulty of the parametric method to ensure successful Gaussian
Fig 4. Distribution of reference values and reference intervals for selected CBC parameter. F: female, Hb: haemoglobin, LAVE: latent abnormal value exclusion, M:
male, MCV: mean corpuscular volume, Plt: platelet count, RBC: red blood cell count, RDW: red cell distribution width, WBC: white blood cells.
https://doi.org/10.1371/journal.pone.0198444.g004
Complete blood count reference intervals from Kenya
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transformation by use of the Box-Cox power transformation formula. However, Ichihara K
and Boyd J proved that by use of a modified Box-Cox formula with addition of transformation
origin in the original formula led to a dramatic change in goodness-of-fit of the transformation
[14]. Besides, the optimal value of power for Gaussian transformation predicted by the
parametric method is fairly consistent analyte by analyte [15], a fact supporting the reliability
of the parametric method. In fact, for the RVs of all the analytes, the parametric method suc-
cessfully led to a Gaussian shape judged from values of skewness and kurtosis as well as from
the linearity in the probability paper plot (S3 Fig). These are the reasons for our adoption of
RIs derived by the parametric method.
A decline in Hb level was associated with an increase in platelet count. Iron deficiency anae-
mia (IDA) and iron deficient erythropoiesis have been associated with secondary thrombocy-
tosis. Conversely, iron supplementation in iron deficient individuals has been shown to
increase Hb levels while reducing platelet count [29]. This inverse relationship between Hb
level and platelet count may explain the higher median platelet count in women in this study
as well as some of the other published studies from SSA [7,21]. Schloesser et al. compared
platelet counts in patients with IDA to healthy controls and found an average platelet count of
499,000/μL in IDA patients compared to 242,000/μL in controls [30]. The mechanism behind
the relationship between Hb level and platelet count isn’t well understood. Various hypothesis
have been put forward including homology between erythropoietin and thrombopoietin
resulting in proliferation and differentiation of pluripotent erythroid and megakaryocyte pre-
cursors, synergistic action of erythropoietin and thrombopoietin in megakaryocyte maturation
and a direct effect of iron on thrombopoiesis [31,32]. Indeed, serum iron and ferritin levels
Table 3. Parametric complete blood count reference intervals after latent abnormal value exclusion.
Male + Female Male Female
Item N LL- UL N LL-UL N LL-UL
RBC (x10^12/L) 463 4.41–6.48 226 4.94–6.52 229 4.31–5.76
Hb (g/dL) 470 12.8–19.0 232 14.5–18.7 236 12.0–16.5
Hct (L/L) 471 0.38–0.55 232 0.43–0.55 237 0.36–0.49
MCV (fl) 466 75.7–95.6 228 76.5–95.5 232 73.4–95.8
MCH (pg) 462 24.8–32.8 227 25.1–32.8 230 24.4–32.7
MCHC (g/dL) 461 32.2–35.2 227 32.4–35.4 230 32.0–35.0
RDW (%) 460 11.3–15.2 225 11.3–14.7 228 11.4–15.8
WBC (x10^9/L) 464 3.08–7.83 229 3.13–8.10 232 2.89–7.72
Neu (%) 463 28.0–63.3 227 27.4–60.3 230 29.5–65.4
Lym (%) 463 27.2–60.0 227 28.2–60.3 230 25.5–59.3
Mon (%) 461 3.4–13.3 226 3.5–14.3 229 3.2–11.0
Eos (%) 455 1.1–11.9 225 1.2–11.8 227 0.8–9.4
Bas (%) 456 0.30–1.10 224 0.40–1.20 228 0.30–1.00
Neu (x10^9/L) 460 1.05–4.08 227 1.02–3.92 229 1.07–4.42
Lym (x10^9/L) 461 1.29–3.40 226 1.36–3.58 230 1.22–3.24
Mon (x10^9/L) 462 0.14–0.74 227 0.15–0.76 229 0.14–0.68
Eos (x10^9/L) 460 0.04–0.59 226 0.05–0.64 228 0.04–0.49
Bas (x10^9/L) 461 0.01–0.07 226 0.01–0.08 224 0.01–0.06
PLT (x10^9/L) 464 144–409 231 133–356 232 152–443
%: percentage, LL: lower limit, UL: upper limit, RBC: red blood cell count, Hb: haemoglobin, MCV: mean corpuscular volume, MCH: mean corpuscular haemoglobin,
MCHC: mean corpuscular haemoglobin concentration, RDW: red cell distribution width, WBC: white blood cell count, Neu: neutrophil, Lym: lymphocyte, Mon:
monocyte, Eos: eosinophil, Bas: basophil, Abs: absolute count, Plt: platelet count. Recommended RIs are shown in bold.
https://doi.org/10.1371/journal.pone.0198444.t003
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Fig 5. Graphical comparison of reference intervals (RIs) for RBC related parameters. Three bars for each study
represent RIs for male+female (MF) in grey, male (M) in blue, and female (F) in red. RIs of this study is shown on top
of each panel. The background shades in blue and pink represent RIs of this study for males and females. LL: lower
limit, UL: upper limit, RBC: red blood cell count, Hb: haemoglobin, Ht: haematocrit, MCV: mean corpuscular volume,
MCH: mean corpuscular haemoglobin, MCHC: mean corpuscular haemoglobin concentration 1Exclusion criteria:
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were lower in female participants in our study while transferrin levels were higher, a common
finding in iron deficient states. Sex was a significant source of variation in platelet counts
(SDRsex = 0.45) in this study and therefore we adopted sex specific RIs for PLT. As shown in
Fig 6, women generally have higher platelet counts than men.
The UL for the parametrically derived absolute eosinophil count in our study was 590 cells/
μL which is much lower than that reported by Karita et al. (1530 cells/μL) and Kibaya et al.
(1140 cells/ μL) both of whom did studies in Kenya but recruited largely a rural population
[6,7]. It is possible that the higher eosinophil counts in the rural population is due to a bigger
burden of parasite infection or greater exposure to environmental allergens. Karita et al. men-
tions that in a sub-study done in Lusaka-Zambia, Entebbe-Uganda and Kigali-Rwanda, up to
one third of stool samples had ova or parasites possibly explaining the higher eosinophil counts
[6]. Given that our study population was largely comprised of an urban working population,
the prevalence of stool parasites would be expected to be low. Measurement of serum IgE
levels and evaluation of stool samples would have provided objective evidence to explore this
hypothesis.
We used SDRs to determine whether sex or age were significant sources of variation neces-
sitating partitioning of RIs. This is a method widely adopted in the studies by Ichihara et al.
and is useful when evaluating more than one source of variation, especially when any source of
variation consists of more than 2 categories [1,11]. An unexpected finding was the decline in
monocyte levels with increase in age for female participants (S1 Fig). With lack of reports on
similar observation, no obvious explanation is forthcoming, hence further studies are required
to investigate the consistency of this finding and its significance.
RIs are used in developing guidelines for defining laboratory adverse events to be used
when enrolling and following up patients in a clinical trial. In many HIV clinical trials, the
Division of AIDS (DAIDS), National Institute of Allergy and Infectious Disease/National
Institutes of Health adverse event tables are used to evaluate toxicities [33]. As highlighted by
Karita et al., adopting the 2004 DAIDS grading criteria would inadvertently misclassify many
healthy study volunteers as having adverse events at the time of clinical trial recruitment. In
BMI> 35 kg/m2, consumption of ethanol 70 g per day, smoking more than 20 tobacco cigarettes per day, chronic
illness, recent recovery from acute illness, injury or surgery requiring hospitalization, known carrier state of HBV,
HCV or HIV, pregnant or within 1 year after child birth. CBC analyser: Beckman Coulter ACT 5 DIFF CP analyser
(Brea, California, US). 2Exclusion criteria: Febrile, pregnant, HIV seropositive, screen positive for syphilis and
malaria. CBC analyser: ACT 5Diff CP instrument (Beckman Coulter, Fullerton, CA, USA) [7]. 3Exclusion criteria:
HIV positive, pregnant. CBC analyser: Coulter ACT 5Diff CP analyser (Beckman Coulter, France) [18]. 4Exclusion
criteria: HIV positive, moribund, mentally ill, institutionalized persons, missing personal or laboratory data. CBC
analyser: Act 5 Diff instrument (Beckman Coulter) [19]. 5Exclusion criteria: Acutely ill, significant findings on
physical examination or if laboratory tests revealed that they were pregnant, HIV antibody positive, had evidence of
hepatitis B or C infection or suspected syphilis. CBC analyser: Beckman Coulter AcT 5 diff CP (Beckman Coulter,
USA) [6]. 6Exclusion criteria: HIV positive, presence of any illness as defined by the World Health Organization
staging systems for HIV infection and disease. CBC analyser: Coulter counter T540 [20]. 7Exclusion criteria: HIV
positive, pregnant or on medication, body temperature37.5˚C or if clinical assessment revealed other signs or
symptoms of disease that could influence the laboratory parameters of interest. CBC analyser: Sysmex KX-21N
analyser (Sysmex Corp., Kobe, Japan) [21]. 8Exclusion criteria: Alcohol abuse, medication, smoking, pregnant,
breastfeeding, on oral contraception, on menses. CBC analyser: Coulter AcT 5diff and Sysmex KX-21N (Sysmex
Corporation, Kobe, Japan) [22]. 9Exclusion criteria: Acute or chronic respiratory, cardiovascular, gastrointestinal,
hepatic or genitourinary conditions, blood donation or transfusion within the past 3 months, hospitalisation within
past 1 month, any findings that would compromise laboratory parameters, pregnant or lactating mothers. CBC
analyser: Micros 60 analysers (Horiba-ABX, Montpellier, France) [23]. 10Exclusion criteria: HIV, HBV, and HCV
viral infection, malaria, abnormal haemoglobin electrophoresis screening, presence of hypochromia. CBC analyser:
Sysmex SF-3000 (Sysmex, Kobe, Japan) [24]. 11Exclusion criteria: HIV, current clinical symptoms,
immunosuppressive or corticosteroid medication, chemotherapy, hospitalizations, surgery or blood transfusions in the
six months prior to screening, splenomegaly, pregnant, Hb< 12 g/dL. Menstruating women returned in 2 weeks. CBC
analyser: Beckman Coulter LH 750 (Beckman Coulter, Fullerton, CA, USA) [25].
https://doi.org/10.1371/journal.pone.0198444.g005
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Fig 6. Graphical comparison of reference intervals (RIs) for WBC related parameters and platelets. Three bars for
each study represent RIs for male+female (MF) in grey, male (M) in blue, and female (F) in red. RIs of this study is
shown on top of each panel. The background shades in blue and pink represent RIs of this study for males and females.
WBC: white blood cell count, Neu: Neutrophil, Lym: lymphocyte, Mon: monocyte, Eos: eosinophil, abs-absolute
count, Plt-platelet count 1Exclusion criteria: BMI> 35 kg/m2, consumption of ethanol 70 g per day, smoking more
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the study, 319 (15.2%) individuals would have been misclassified as having a haematology lab-
oratory adverse event which would have resulted in their unnecessary exclusion from the
study [6]. Given the marked variability in certain CBC parameters across different populations,
population specific RIs should be used when defining laboratory based adverse events for clini-
cal trials. Failure to do so will not only result in inappropriate exclusion or inclusion of study
participants but misreporting on the incidence of toxicities.
The major strength of this study is the careful recruitment of healthy individuals with an
even distribution of age and sex. Unlike most of the other RI studies conducted in SSA, we
had strict exclusion criteria and further carried out secondary exclusion which significantly
reduced the influence of individuals with latent anaemia or inflammation. This increases the
external validity of the results in so far as extrapolating to an adult urban black African popula-
tion in Kenya is concerned.
One of the limitations of this study was that sample analysis was done only on a Beckman
Coulter analyzer hence the transferability of the RIs is limited if between-analyzer bias exists in
test results. Secondly, our recruitment comprised largely an urban population, the vast major-
ity from the capital city Nairobi and surrounding counties whose socio-economic status and
lifestyles are different from a rural population. Some of the RIs may therefore not be directly
applicable to a rural community. Another limitation is that we relied on self-reporting of
chronic illnesses including those of an infectious aetiology. It is possible that some participants
may not have provided accurate information and as such may have ended up being included
inadvertently. We however tried to minimize the effect of such inclusion by secondarily
excluding individuals whose test results suggested the possibility of sub-clinical disease.
Conclusion
The present study highlights marked differences in certain CBC parameters such as Hb, eosin-
ophil and platelet counts compared to other SSA countries and lower neutrophil counts com-
pared to the US. To the best of our knowledge this is the first study from Africa that has used
the LAVE procedure to determine RIs for CBC and we do believe that the secondary exclusion
than 20 tobacco cigarettes per day, chronic illness, recent recovery from acute illness, injury or surgery requiring
hospitalization, known carrier state of HBV, HCV or HIV, pregnant or within 1 year after child birth. CBC analyser:
Beckman Coulter ACT 5 DIFF CP analyser (Brea, California, US). 2Exclusion criteria: Febrile, pregnant, HIV
seropositive, screen positive for syphilis and malaria. CBC analyser: ACT 5Diff CP instrument (Beckman Coulter,
Fullerton, CA, USA) [7]. 3Exclusion criteria: HIV positive, pregnant. CBC analyser: Coulter ACT 5Diff CP analyser
(Beckman Coulter, France) [18]. 4Exclusion criteria: HIV positive, moribund, mentally ill, institutionalized persons,
missing personal or laboratory data. CBC analyser: Act 5 Diff instrument (Beckman Coulter) [19]. 5Exclusion
criteria: Acutely ill, significant findings on physical examination or if laboratory tests revealed that they were pregnant,
HIV antibody positive, had evidence of hepatitis B or C infection or suspected syphilis. CBC analyser: Beckman
Coulter AcT 5 diff CP (Beckman Coulter, USA) [6]. 6Exclusion criteria: HIV positive, presence of any illness as
defined by the World Health Organization staging systems for HIV infection and disease. CBC analyser: Coulter
counter T540 [20]. 7Exclusion criteria: HIV positive, pregnant or on medication, body temperature37.5˚C or if
clinical assessment revealed other signs or symptoms of disease that could influence the laboratory parameters of
interest. CBC analyser: Sysmex KX-21N analyser (Sysmex Corp., Kobe, Japan) [21]. 8Exclusion criteria: Alcohol
abuse, medication, smoking, pregnant, breastfeeding, on oral contraception, on menses. CBC analyser: Coulter AcT
5diff and Sysmex KX-21N (Sysmex Corporation, Kobe, Japan) [22]. 9Exclusion criteria: Acute or chronic respiratory,
cardiovascular, gastrointestinal, hepatic or genitourinary conditions, blood donation or transfusion within the past 3
months, hospitalisation within past 1 month, any findings that would compromise laboratory parameters, pregnant or
lactating mothers. CBC analyser: Micros 60 analysers (Horiba-ABX, Montpellier, France) [23]. 10Exclusion criteria:
HIV, HBV, and HCV viral infection, malaria, abnormal haemoglobin electrophoresis screening, presence of
hypochromia. CBC analyser: Sysmex SF-3000 (Sysmex, Kobe, Japan) [24]. 11Exclusion criteria: HIV, current clinical
symptoms, immunosuppressive or corticosteroid medication, chemotherapy, hospitalizations, surgery or blood
transfusions in the six months prior to screening, splenomegaly, pregnant, Hb< 12 g/dL. Menstruating women
returned in 2 weeks. CBC analyser: Beckman Coulter LH 750 (Beckman Coulter, Fullerton, CA, USA) [25].
https://doi.org/10.1371/journal.pone.0198444.g006
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of individuals with possible sub-clinical disease makes our RIs more representative of a healthy
urban Kenyan population. Our study results can serve as a reference for laboratories in SSA
especially in situations where conducting a formal RI study may not be feasible.
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